OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India, Singapore, the United States, Spain, and internationally. The company provides end-to-end contract development and manufacturing operations (CDMO) services across various phases of pre-clinical ...
Onesource Specl Pharma L reported revenue of 14.45 billion INR for fiscal year 2025, up 740.4% from fiscal year 2024, and net income of -179.71 million INR. In Q2 2026 (the quarter ended September 30, 2025) revenue was 3.76 billion INR, up 12.5% from a year before. Rest of The World was its largest region in fiscal year 2025, with 39% of revenue. Its market capitalization was 168.69 billion INR as of October 12, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2025; market data as of October 12, 2026.
No profile data available.